BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24073851)

  • 1. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
    Liu X; Ladias JA
    Biochemistry; 2013 Oct; 52(43):7618-27. PubMed ID: 24073851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1.
    Campbell SJ; Edwards RA; Glover JN
    Structure; 2010 Feb; 18(2):167-76. PubMed ID: 20159462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
    Manke IA; Lowery DM; Nguyen A; Yaffe MB
    Science; 2003 Oct; 302(5645):636-9. PubMed ID: 14576432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS; Lee MS; Hau DD; Glover JN
    Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif.
    Wu Q; Jubb H; Blundell TL
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):143-148. PubMed ID: 25701377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M; Yu X; Chen J; Songyang Z
    J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.
    Varma AK; Brown RS; Birrane G; Ladias JA
    Biochemistry; 2005 Aug; 44(33):10941-6. PubMed ID: 16101277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
    Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
    Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
    Ekblad CM; Friedler A; Veprintsev D; Weinberg RL; Itzhaki LS
    Protein Sci; 2004 Mar; 13(3):617-25. PubMed ID: 14978302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BRCT regions of tumor suppressor BRCA1 and of XRCC1 show DNA end binding activity with a multimerizing feature.
    Yamane K; Katayama E; Tsuruo T
    Biochem Biophys Res Commun; 2000 Dec; 279(2):678-84. PubMed ID: 11118345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of ATR-interacting protein on Ser239 mediates an interaction with breast-ovarian cancer susceptibility 1 and checkpoint function.
    Venere M; Snyder A; Zgheib O; Halazonetis TD
    Cancer Res; 2007 Jul; 67(13):6100-5. PubMed ID: 17616665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BRCT domain is a phospho-protein binding domain.
    Yu X; Chini CC; He M; Mer G; Chen J
    Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCT domains: phosphopeptide binding and signaling modules.
    Rodriguez MC; Songyang Z
    Front Biosci; 2008 May; 13():5905-15. PubMed ID: 18508631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.
    Botuyan MV; Nominé Y; Yu X; Juranic N; Macura S; Chen J; Mer G
    Structure; 2004 Jul; 12(7):1137-46. PubMed ID: 15242590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS; Green R; Glover JN
    Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma susceptibility protein, Rb, possesses multiple BRCT-Ws, BRCA1 carboxyl-terminus-related W regions with DNA break-binding activity.
    Yamane K; Katayama E; Sugasawa K; Tsuruo T
    Oncogene; 2000 Apr; 19(16):1982-91. PubMed ID: 10803459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA.
    Yamane K; Tsuruo T
    Oncogene; 1999 Sep; 18(37):5194-203. PubMed ID: 10498869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamic study of the BRCT domain of BARD1 and its interaction with the -pSER-X-X-Phe- motif-containing BRIP1 peptide.
    Thanassoulas A; Nomikos M; Theodoridou M; Yannoukakos D; Mastellos D; Nounesis G
    Biochim Biophys Acta; 2010 Sep; 1804(9):1908-16. PubMed ID: 20451671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of the Rad9-binding region of the DNA-damage checkpoint adaptor TopBP1.
    Rappas M; Oliver AW; Pearl LH
    Nucleic Acids Res; 2011 Jan; 39(1):313-24. PubMed ID: 20724438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
    Tischkowitz M; Hamel N; Carvalho MA; Birrane G; Soni A; van Beers EH; Joosse SA; Wong N; Novak D; Quenneville LA; Grist SA; ; Nederlof PM; Goldgar DE; Tavtigian SV; Monteiro AN; Ladias JA; Foulkes WD
    Eur J Hum Genet; 2008 Jul; 16(7):820-32. PubMed ID: 18285836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.